35
Views
40
CrossRef citations to date
0
Altmetric
Original Article

A prospective epidemiological survey of candidaemia in Sweden

, , , , &
Pages 52-55 | Received 24 Jun 2003, Accepted 15 Oct 2003, Published online: 08 Jul 2009

  • Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the US from 1979 through 2000. N Engl J 2003; 348:16.
  • Abbas J, Bodey GP, Hanna HA, Mardani M, Girgawy E, Abi-Said D, et al. Candida krusei fungaemia: an escalating serious infection in imunocompromised patients. Arch Intern Med 2000; 160: 2659–64.
  • Edmond MB, Wallace SE, McClish DK, Phaller MA, Jones RN, Wenzel RP. Nosocomial blood stream infections in US hospitals: a 3-y analysis. Clin Infect Dis 1999; 29: 239–44.
  • Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance programme in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 2000; 44: 747–51.
  • Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996; 22(Suppl 2): S89–94.
  • Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital acquired candidaemia: the attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642–5.
  • Wenzel RP, Edmond MB. The impact of hospital acquired bloodstream infections. Emerg Infect Dis 2001; 7: 174–7.
  • Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, et al. The epidemiology of candidaemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164–70.
  • Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526–30.
  • Beck-Sagué CM, Jarvis WR and the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 1993; 167:1247–51.
  • Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Benney J. The direct cost and incidence of systemic fungal infections. Value in Health 2002; 5: 26–34.
  • ECMM Mycology Newsletter 1997; 0/97: 12–14.
  • McDonald LC, Weinstein MP, Fune J, Mirrett Seimer LG, Reller LB. Controlled comparison of BacT ALERT FAN aerobic medium and BACTEC fungal blood culture medium for detection of fungaemia. J Clin Microbiol 2001; 39: 622–4.
  • Verweij PE, Meis JF. Microbiological diagnosis of invasive fungal infections in transplant recipients. Transpl Infect Dis 2000; 2: 80–7.
  • Ascioglu S, Rex JH, de Pauw B, Bennet JE, Bille J, Crokaert F, et al. Invasive Fungal Infections Cooperative Group, The European Organization for Research and Treatment of Cancer, Mycoses Study Group of the National Institute of Allergy and Infectious Disease. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and haemapoetic stem cell transplants; an international consensus. Clin Infect Dis 2002; 34: 7–14.
  • Nucci M, Colombo AL, Silveira F, Richtman R, Saomao R, Brand ML, Spector N. Risk factors for death in patients with candidaemia. Infect Control Hosp Infect 1998; 19: 846–50.
  • Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Phaler MA, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicentre study. Clin Infect Dis 2001; 33: 177–86.
  • Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidaemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002; 40: 3551–7.
  • Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, et al. Candida infections: outcome and attributable ICU cost in critically ill patients. J Int Care Med 2000; 15: 255–61.
  • Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115–25.
  • Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, et al. Candidaemia in cancer patients: a prospective, multicentre surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28: 1071–9.
  • Sandven P. Epidemiology of candidaemia. Rev Iberoam Micol 2000; 17: 73–81.
  • Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ. SENTRY Participants Group. Trends in antifungal susceptibility of Candida spp. isolated in paediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 2002; 40: 852–6.
  • Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000; 30: 662–78.
  • Kossof EH, Buescher ES, Karlowicz MG. Candidaemia in a neonatal intensive care unit: trends during 15 y and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17: 504–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.